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Abstract
Background: Protein kinases and phosphatases regulate protein phosphorylation, a critical means of
modulating protein function, stability and localization. The identification of functional networks for protein
phosphatases has been slow due to their redundant nature and the lack of large-scale analyses. We
hypothesized that a genome-scale analysis of genetic interactions using the Synthetic Genetic Array could
reveal protein phosphatase functional networks. We apply this approach to the conserved type 1 protein
phosphatase Glc7, which regulates numerous cellular processes in budding yeast.
Results: We created a novel glc7 catalytic mutant (glc7-E101Q). Phenotypic analysis indicates that this
novel allele exhibits slow growth and defects in glucose metabolism but normal cell cycle progression and
chromosome segregation. This suggests that glc7-E101Q is a hypomorphic glc7 mutant. Synthetic Genetic
Array analysis of glc7-E101Q revealed a broad network of 245 synthetic sick/lethal interactions reflecting
that many processes are required when Glc7 function is compromised such as histone modification,
chromosome segregation and cytokinesis, nutrient sensing and DNA damage. In addition, mitochondrial
activity and inheritance and lipid metabolism were identified as new processes involved in buffering Glc7
function. An interaction network among 95 genes genetically interacting with GLC7 was constructed by
integration of genetic and physical interaction data. The obtained network has a modular architecture, and
the interconnection among the modules reflects the cooperation of the processes buffering Glc7 function.
Conclusion: We found 245 genes required for the normal growth of the glc7-E101Q mutant. Functional
grouping of these genes and analysis of their physical and genetic interaction patterns bring new
information on Glc7-regulated processes.
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Background
Regulation of phosphorylation state is a mechanism for
controlling the function, localization and stability of pro-
teins in vivo and is critical for the regulation of essential
processes such as polarity and morphogenesis, chromo-
some segregation, cytokinesis, and cell cycle control [1-4].
Together, protein kinases (which mediate phosphoryla-
tion) and protein phosphatases (PPases) (which mediate
de-phosphorylation) provide precise temporal and spatial
regulation of their target substrates. In the budding yeast
Saccharomyces cerevisiae, the dynamic localization of
PPases suggests that an extensive cross talk between these
processes is critical for the proper execution of cell divi-
sion [2,5]. However, many of the substrates and regula-
tory proteins that participate in this cross talk remain
unidentified. Insight into PPase function has lagged sig-
nificantly in comparison to kinases since PPases: (1) fre-
quently require regulatory proteins that determine their
targeting to particular substrates, cellular location or proc-
ess and (2) often exhibit considerable functional redun-
dancy. In budding yeast, for example, ~90% of the known
32 PPases are non-essential [6].
Study of genetic interaction networks is a powerful means
to get insight into gene function, and several high
throughput methods were developed during the last dec-
ade to generate genome-wide maps of genetic interactions
[7-13]. However, such maps are still missing for yeast
PPases. To date investigations of PPase function in bud-
ding yeast have utilized mutations outside the catalytic
site [5,14-16] or probed genetic interactions using single
or double knockout PPase mutations [6]. These
approaches present constraints for large-scale analysis of
PPase function since: (1) mutations outside the catalytic
domain generally affect the formation of a specific class of
holoenzyme or the ability to interact with co-factor(s)
required for the proper targeting of the PPase to a subset
of substrates [17-19], and (2) the use of knockout alleles,
in addition to precluding the analysis of the essential
PPases, may lead to promiscuous and/or low-affinity
interaction of regulatory subunits with PPases of the same
class. For these reasons, we designed a strategy based on a
hypomorphic catalytic PPase mutation that uses the Syn-
thetic Genetic Array (SGA). This method generates a large
number of double mutant combinations, and has been
successfully used to identify genetic interaction networks
in yeast in a wide range of cellular processes
[12,13,20,21].
In the budding yeast Saccharomyces cerevisiae, 32 genes
encode predicted or demonstrated catalytic subunits of
PPases. Only two of these PPases are clearly essential: the
PP1-type PPase, Glc7 (glycogen deficient) [1,22], and
Cdc14 (cell division cycle), a dual-specificity phosphatase
that regulates mitotic/meiotic exit [23]. We selected Glc7
for our analyses since a framework of genetic and protein
interactions exists from previous studies of conditional
glc7  mutants, but a comprehensive large-scale genetic
analysis had not yet been performed. Glc7 critically regu-
lates numerous processes such as glucose and glycogen
metabolism, sporulation, chromosome segregation, mei-
osis, mRNA transport, transcription, and amino acid bio-
synthesis [1,3,15,17,22,24,25]. A search in the BioGRID
database (version 2.0.41, June 1, 2008 [26]) returned a list
of 114 proteins reported to physically interact with Glc7.
Some of these proteins are known substrates (Cbf2, Fin1,
Red1, Gsy2), while others are thought to be regulatory
subunits (Gac1, Reg1, Reg2, Ref2, Sip5, Glc8, Bud14,
Bni4, Sds22). However, the functional significance of the
majority of these interactions remains unclear. In con-
trast, only 30 genes have been reported to show genetic
interactions with various glc7 mutants. The vast majority
of these genetic interactions are dosage dependent and
only 7 genes (BUD14, DAM1, DOC1, GLC8, RHR2,SET1
and SLT2) have been reported to show synthetic lethal/
sick interaction with different conditional glc7 alleles. The
functional clustering of genetic interactions of conditional
glc7 alleles suggests the majority of these mutations com-
promise specific aspects of Glc7 function. As such, these
alleles are highly suited for cell biology. However an unbi-
ased large-scale analysis revealing a comprehensive pic-
ture of Glc7 signaling in vivo requires a novel glc7 allele
affecting many functions of Glc7 at a time.
In an effort to further define the signaling network for
Glc7, we created a novel glc7  catalytic mutant (glc7-
E101Q) suitable for SGA. The glc7-E101Q mutant exhib-
ited slow growth and impaired glycogen accumulation on
glucose, but no specific delay in the cell cycle. The
impaired growth and defects in glycogen synthesis of the
glc7-E101Q mutant were rescued by introduction of a sin-
gle copy of wild type GLC7, indicating that glc7-E101Q is
a recessive, hypomorphic allele. SGA analysis revealed a
broad network of 245 synthetic sick/lethal (SSL) interac-
tions that encompassed all known Glc7-regulated proc-
esses, and suggested additional previously unknown
functions for Glc7.
Results
Creation of a catalytic-deficient GLC7 mutant, glc7-
E101Q
Glc7 is the sole essential member of the PPP family of
PPases in budding yeast and members of this family share
a conserved catalytic motif. Residues in the Glc7 catalytic
domain (CD1-3) are evolutionarily conserved with
human PP1 orthologs and the PP1-like bacterial λ-PPASE
(Figure 1A). Given the high degree of conservation in the
catalytic residues, Glc7 is expected to have catalytic char-
acteristics similar to those of previously characterized
PP1-type PPases. Phosphate hydrolysis by PP1 occurs viaBMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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Structure of PP1 catalytic motif and the glc7-E101Q mutant Figure 1
Structure of PP1 catalytic motif and the glc7-E101Q mutant. (A) PP1 protein phosphatases have highly conserved cat-
alytic domains, consisting of residues acting as an acidic catalyst for phosphotransfer (CD1 and CD2) from the substrate and a 
phospho acceptor hisidine residue (CD3). Residues in the catalytic pocket are highly conserved between human (PP1), yeast 
PPP-type PPases (Glc7 and others) and the bacterial PPase, λ-PPASE. (B) Left panel: The Glc7 catalytic pocket (pink) was mod-
eled using the tertiary structure of human PP1C-γ (PDB Model 1jk7A; blue). Right panels: The E101Q mutation is predicted to 
inhibit the binding of a metal cation required to accelerate phospho-transfer to H124, but to not alter the shape/size of the cat-
alytic pocket relative to wild type Glc7.
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a onestep reaction and is dependent on metal ion catalysts
(Mn2+ and Fe2+). This hydrolysis reaction (Additional File
1) is dependent on a phosphoesterase motif
DXH(X)nGDXXD(X)nGNHD/E (where n = ~25 amino
acids) whose active residues are a general acid catalyst
(H124 in Glc7) and the carboxyl oxygen of two invariant
aspartic acids (D91 and D94 in Glc7) [27]. Similar to
human PP1 and Glc7, λ-PPASE (a bacteriophage ortholog
of PP1) shares this conserved catalytic domain (Figure 1A)
and has been previously examined in structure-function
analyses of the active residues in the catalytic pocket.
Mutation of either D49 or D52 (D92 and D95 in PP1C-γ;
D91 and D94 in Glc7, respectively) to a non-reactive
asparagine residue (D>N) resulted in a catalytically dead
enzyme in in vitro PPase assays. However, mutation of E59
(E>Q; E102 in PP1C and E101 in Glc7) reduced the cata-
lytic activity of λ-PPASE ~8 fold and impaired Mn2+
recruitment, but did not significantly alter its substrate
binding [28]. An E>Q substitution in the equivalent resi-
due of Glc7 (E101Q) is therefore predicted to reduce cat-
alytic activity by perturbing the recruitment of the metal
co-factor that enhances phospho-transfer. Using human
PP1C-γ as a template, we found that the conserved resi-
dues of Glc7 in the CD1-3 regions form a tertiary structure
very similar to human PP1. Furthermore, analysis of the 3-
D model of the E101Q mutation in Glc7 indicated that
the overall shape and size of the catalytic pocket was not
significantly changed (Figure 1B). We predicted that
reduction of Glc7 catalytic activity in vivo, as a result of the
E101Q mutation, would result in a recessive, hypomor-
phic glc7 allele suitable for an unbiased SGA analysis.
glc7-E101Q mutant exhibits slow growth but no 
appreciable cell cycle delay or defect in chromosome 
segregation
The introduction of a glc7-D91N mutation into diploid
cells resulted in inviable haploid progeny by tetrad dissec-
tion (data not shown). This finding is consistent with the
previous observation that this mutation results in a cata-
lytically dead form of the enzyme in vivo [28]. In contrast,
haploid glc7-E101Q colonies isolated by tetrad dissection
were viable but consistently small compared to wild type
(GLC7) when grown on rich medium (YPAD) (data not
shown). Analysis of the growth curve for three haploid
isolates of glc7-E101Q indicated impaired kinetics com-
pared to wild type cells (Figure 2A). To determine whether
slow growth was due to a delay in cell cycle progression,
mutant and wild type cells from log phase cultures were
harvested, stained with propidium iodide and DNA con-
tent measured by FACS analysis. As shown in Figure 2B,
FACS analysis revealed that proportion of G1, S, or M-
phase cells in glc7-E101Q cultures was not statistically dif-
ferent from that of wild type cells. This result correlated
with the observation that proportion of unbudded, small-
budded and large-budded cells was similar between wild
type and glc7-E101Q strains (Figure 2C).
Studies using conditional glc7  mutants have demon-
strated a role for Glc7 in the attachment of spindle micro-
tubules to kinetochores during metaphase and
chromosome segregation [1,29-33]. Therefore, we next
examined glc7-E101Q cells for chromosome segregation
defects and sensitivity to the microtubule-destabilizing
agent, benomyl. To examine bi-orientation of sister chro-
matids, anaphase cells (mitotic spindle>2.5 μm) express-
ing GFP-LacI and centromeric repeats (CEN15) of the
lactose operon (lacO) [34] were examined by fluorescence
microscopy. As shown in Figure 2D, GFP-LacI segregated
to both spindle pole bodies (marked by the spindle pole
marker, Spc29-CFP) in a similar manner to wild type cells.
We also examined for chromosome mis-segregation in
glc7-E101Q cells following several growth cycles using a
sectoring assay [35]. Wild type, glc7-E101Q and ame1-6
(positive control) strains lacking a functional ADE2 gene
(ade2Δ-101) were transformed with a centromeric frag-
ment of chromosome III containing the SUP11 gene (Cir-
cle III/SUP11) and analyzed for loss of the fragment after
4-day incubation on YPD medium lacking adenine. The
ame1-6  strain exhibited frequent chromosome loss as
indicated by the appearance of red sectors in the colonies
(Figure 2E). In contrast, glc7-E101Q and wild type colo-
nies induced negligible loss of the Circle III/SUP11 frag-
ment, and the vast majority of colonies remained white in
coloration (Figure 2E). We also tested glc7-E101Q cells for
sensitivity to the microtubule-disrupting agent, benomyl.
When compared to the wild type, glc7-E101Q cells had
consistently slower growth on both DMSO control and
benomyl plates. However, the slow growth of glc7-E101Q
was not exacerbated by benomyl treatment (Figure 2F).
To investigate the possibility that the slow growth pheno-
type of glc7-E101Q cells might be the result of either pro-
tein instability or changes in protein modifications to
Glc7, whole cell extracts were examined by Western blot
analysis. Protein extracts from strains expressing Glc7-
ProA or glc7-E101Q-ProA fusion proteins were prepared
from asynchronous cells (1D immunoblot) or from G1, S
and G2/M-arrested cells (2D immunoblot) and examined
using anti-ProA antibodies. The abundance of the glc7-
E101Q-ProA mutant was not reduced relative to wild type
Glc7-ProA by 1D immunoblot analysis (Additional File
2A). Furthermore, in each case, a single isoform was iden-
tified for Glc7-ProA and glc7-E101Q-ProA in extracts
derived from G1, S and G2/M arrested cells (Additional
File 2B). These findings indicate that the slow growth of
glc7-E101Q strains was not the result of protein instability
or the accumulation of aberrant modifications to the Glc7
protein.BMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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glc7-E101Q mutant exhibits slow growth but no appreciable delay in the cell cycle or chromosome segregation defect Figure 2
glc7-E101Q mutant exhibits slow growth but no appreciable delay in the cell cycle or chromosome segregation 
defect. (A) The growth of wild type (GLC7) vs glc7-E101Q strains in rich medium (YPAD) was determined from early log-
phase cultures. (B) FACs analysis for DNA content (propidium iodide staining) of log-phase wild type and glc7-E101Q cells. Cell 
counts are shown plotted against fluorescence intensity (PI). (C) Budding index of wild type and glc7-E101Q mutant strains. (D) 
Fluorescence microscopy of anaphase cells (mitotic spindle >2.5 μm) wild type and glc7-E101Q cells expressing a chromosome 
[GFP-LacI (green) and centromeric (CEN15) repeats of the lactose operon (lacO)] and spindle pole body (SPB) [Spc29-CFP 
(red)] markers. The percentage of cells with chromosomes localized to both SPBs is indicated at the bottom (n = 3, 300 cells/
experiment). (E) Test for chromosome segregation using a sectoring assay. Wild type GLC7, glc7-E101Q and ame1-6 strains 
lacking a functional ADE2 gene (ade2Δ-101) and transformed with a Circle III/SUP11 were plated on to medium lacking adenine 
(YPD) and scored for appearance of red sectors after 4-day incubation. (F) Spotting assay of glc7-E101Q vs. wild type on 
DMSO control or benomyl plates (5-fold serial dilutions of 1.0 × 106 cells/ml; 5 μl/spot). Benomyl-sensitive (tub1-1) and resist-
ant (tub2-104) strains were plated as controls.BMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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glc7-E101Q mutant is impaired in glucose metabolism
Glc7 has a well-established role in glucose metabolism.
The first conditional allele of glc7 (glc7-1) was isolated as
a consequence of its defect in glycogen synthesis in the
presence of glucose [36], a phenotype that has, similarly,
been observed for other glc7 mutants [22,36]. The failure
to accumulate glycogen has been linked to impaired de-
phosphorylation of the glycogen synthase, Gsy2, by Glc7
and its targeting subunit, Gac1 [15,37]. Glc7 also plays an
important role in glucose repression, a process that (in the
presence of glucose) leads to transcriptional repression of
genes involved in the utilization of alternative carbon
sources such as sucrose, galactose and maltose. Condi-
tional  glc7  mutants such as glc7-T152K  [25,38],  glc7-
F256A, glc7-F292A, glc7-E241 L242 [16] exhibit defects in
glucose repression that is due, in part, to an impaired abil-
ity of the Glc7 mutant to associate with the targeting sub-
unit Reg1. In the presence of glucose, Glc7-Reg1 has been
shown to de-phosphorylate and thereby, inhibit Snf1
kinase, which is responsible for the transcription of sev-
eral glucose-repressed genes [25,39]. We observed that
glc7-E101Q cells had a more significant growth defect in
limited glucose (2% glycerol, 0.08% glucose; YPAG) rela-
tive to its growth in rich medium (2% glucose; YPAD).
Growth of glc7-E101Q cells on both YPAD and YPAG was
similar at 30°C and 37°C, indicating the glc7-E101Q
mutation does not induce temperature-sensitivity (Figure
3A). Glycogen content was assessed by iodine staining
[40] and revealed impaired glycogen accumulation for
glc7-E101Q cells (Figure 3B). Both the impaired growth
and the glycogen accumulation defects of glc7-E101Q
were restored to wild type levels in strains that expressed
an un-linked copy of wild type GLC7:URA3 inserted at the
ura3 locus (GLC7-res).
To rule out the possibility that the poor growth of glc7-
E101Q observed on YPAG is the consequence of a petite
phenotype resulting from mitochondrial mis-function,
tetrad analysis was performed on diploid cells hetero-
zygous for glc7-E101Q  in a genetic background
homozygous for a defective ade2Δ-101  gene. In the
absence of adenine, ade2Δ-101 cells accumulate P-ribo-
sylaminoimidazole, an intermediate of the adenine syn-
thesis pathway. Mitochondrial oxidation of this
intermediate results in a red pigment which colors colo-
nies [41]. We observed glc7-E101Q spore colonies consist-
glc7-E101Q mutant is impaired in glucose metabolism Figure 3
glc7-E101Q mutant is impaired in glucose metabolism. (A) Growth of wild type (GLC7), mutant (glc7-E101Q) and res-
cue (glc7-E101Q/GLC7-res) strains was examined by spotting assays (5-fold serial dilutions of 1.0 × 106 cells/ml; 5 μl/spot) grown 
in YPAD or YPAG for 48 hr at 30°C and 37°C. (B) Glycogen content was assessed in wild type (GLC7), mutant (glc7-E101Q) 
and rescue (GLC7-res) strains by iodine staining. Brown color correlates with glycogen content.
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ently accumulated this red pigment on medium lacking
adenine demonstrating the presence of functional mito-
chondria (data not shown). Taken together, these results
support that the glc7-E101Q mutation is a stable recessive
allele and exhibits impaired catalytic activity in vivo.
SGA analysis of glc7-E101Q reveals a broad genetic 
network encompassing Glc7-regulated processes
In order to expand the genetic network of Glc7 and to
identify new candidate genes involved in Glc7-dependent
processes, we screened ~4,600 non-essential genes for
synthetic interactions with glc7-E101Q  using the SGA
methodology (Additional Files 3 and 4). Two-independ-
ent genome-wide screens revealed a total of 786 candidate
synthetic sick/lethal (SSL) interactions (Additional File 4).
To confirm SSL genes identified, we utilized a modified
spot assay version of random spore analysis described pre-
viously [13]. Since Glc7 has been shown to regulate sporu-
lation [19,22,42] and meiosis [43,44] we wished to rule
out the possibility that genes identified as SSL with glc7-
E101Q may have resulted from meiotic and/or sporula-
tion defects due to haploinsufficiency for GLC7. To cir-
cumvent this problem, random spore analysis was
performed using a query strain of glc7-E101Q that con-
tained  GLC7:URA3  under control of the endogenous
GLC7 promoter inserted in the ura3 locus (GLC7-res) (see
Methods and Additional File 3). Using this methodology,
mating, sporulation and selection of MATa haploid prog-
eny were performed under conditions in which wild type
GLC7 was co-expressed in the glc7-E101Q mutant. Follow-
ing the selection of MATa progeny, cells expressing wild
type GLC7 were eliminated by plating on 5-fluoro-orotic
acid (5-FOA) medium which prevents the growth of cells
expressing a functional URA3  gene [45]. Plate scoring
from the random spore analysis confirmed 245 genes as
SSL with glc7-E101Q. The SSL genes were then grouped
into functional classes according to their biological proc-
ess GO (Gene Ontology) annotations deposited in the
Saccharomyces  Genome Database (GO-slim mapping
table, downloaded on June 4th, 2008). Additional File 5
lists the 494 annotations encompassing 35 high-level GO
terms for the 245 SSL genes. Using a hypergeometric dis-
tribution model [46], the frequency distribution of the
GO terms identified for SSL genes was compared to those
represented in the deletion array and examined for enrich-
ment of particular biological processes (Figure 4 and
Additional File 6). The set of SSL gene annotations was
significantly enriched for 5 GO-terms: Organelle Organi-
zation and Biogenesis (p < 0.01); Protein modification
process (p < 0.05); Anatomical Structure Morphogenesis
(p < 0.05); Nuclear Organization (p < 0.01); and Biogen-
esis and Cell Budding (p < 0.05). Since Glc7 has been
shown to play a role in all these processes, this suggests
that the glc7-E101Q  mutant is defective in multiple
aspects of the Glc7 function.
To reveal the processes buffered by GLC7, 163 of 245
genes interacting with the glc7-E101Q mutant were man-
ually grouped into 12 functional categories (Table 2). The
majority of these genes are implicated in critical cellular
processes such as chromosome segregation, nutrient-sens-
ing, stress response and mitochondrial function. The
information currently available on the remaining set of
genes is too fragmental to allow classification in any of the
listed categories (Additional File 5).
Chromatin remodeling, chromosome segregation, DNA damage, cell 
polarity and cytokinesis genes
A set of genes encoding histone-modifying proteins with
a role in chromatin remodeling and transcription show
SSL interaction with glc7-E101Q. This group includes the
histone H3 acetyltransferase RTT109/KAT11, the histone
H3 methylase DOT1/KMT4, the component of the Rpd3
histone deactylase PHO23, the subunit of the SAGA/SLIK
complexes  CHD1  involved in histone acetylation, the
peptidyl-prolyl cis-trans isomerase FPR4 involved in his-
tone H3 and H4 folding, the nucleosome remodeling fac-
tor ASF1, and the histone-associated factor UAF30. These
results are in agreement with a previous observation that
doc1Δ glc7-127 double mutants exhibited a slow growth
phenotype due to mis-regulation of histone H3 phospho-
rylation [47]. In addition, the loss of SET1, which encodes
a histone methyltransferase, was also shown to cause
lethality in glc7-127 cells [48]. Collectively, these findings
indicate that correct histone modification is required for
the survival of glc7 mutants.
Genes with a role in DNA damage included components
of chromatin remodeling complexes (IES2 and RSC2), the
checkpoint signaling gene, MRC1, subunits of DNA-repair
complexes (EXO1, LIF1, PMS1, RAD4,RAD14, TDP1 and
UNG1) and DNA-damage responsive genes (LSM12,
RFX1, YFR017C and YPR147C). This set of genes empha-
sizes the requirement for proper chromosome segregation
in glc7-E101Q cells and the critical role of the DNA-repair
machinery during mitosis. Several other genes identified
indicate that Glc7 plays a critical role in chromosome seg-
regation and cytokinesis. Genes in these categories
include regulators of microtubule dynamics (the microtu-
bule +TIP protein BIM1, a-tubulin TUB3, and the Glc7
regulatory subunit BUD14) and the cytokinetic actomy-
osin ring (the formin BNR1, anillin-like protein BOI1,
and two regulators of Rho1 GTPase ROM2  and  BAG7
[49,50]). In addition, AXL2  and BUD4  were identified
which share a physical interaction and are implicated in
cell polarity and cell-cycle control [51]. Other genes
involved in chromosome segregation included chromatid
cohesion genes (CTF8 and REC8), the mini-chromosome
maintenance gene, MCM22, cytokinesis genes (CIK1 and
KAR3), components of the spindle checkpoint (BUB1,
BUB3, MAD1 and MAD2), subunits of the nuclear poreBMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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complex (NUP53, NUP84 and NUP133) and karyopherin
genes (KAP120 and SXM1). The identification of a wide-
spanning range of genes involved in chromosome segre-
gation supports that Glc7 plays a prominent role in buff-
ering against chromosome mis-segregation. This is
supported by previous findings that loss of BUD14 [52] or
mutation of the kinetochore protein, DAM1, [53] caused
lethality of conditional glc7 mutants. Furthermore, other
data supports that Glc7 plays a key role in regulating the
attachment of kinetochore microtubules to chromo-
somes. It is postulated that this regulation occurs via Glc7-
dependent de-phosphorylation of kinetochore-localized
proteins, such as Ndc10 and other yet to be identified sub-
strates [29,30,32].
Nutrient-sensing, stress response and mitochondrial genes
In accordance with Glc7's prominent metabolic role, par-
ticularly glycogen accumulation and glucose repression,
several genes involved in nutrient sensing, metabolism
and stress response were identified. SIP5 and the Snf1-
activating kinase SAK1, which are both involved in the
regulation of Snf1 kinase, were required for growth of
glc7-E101Q. Sip5 physically interacts with both Reg1-Glc7
and Snf1, and is thought to regulate the interaction
between Glc7 and Snf1 [39]. Other nutrient sensing genes
included GPH1 (glycogen phosphorylase), TDH3 (glycer-
aldehyde-3-phosphate dehydrogenase), GPA2 (a-subunit
of the glucose sensor G-protein), TPK1 (cAMP-dependent
kinase involved in the Ras-cAMP signaling pathway),
SSK1 (HOG pathway kinase), CKB1 and CKB2 (β-and β'-
casein kinase subunits) and various transport proteins
(BAP2, HXT17, MCH4, YBR235W and YJL193W). Genes
required for growth under stress conditions (ATG5,
ATG15, HIT1, MCA1, NST1, NVJ1, ORM2, SFL1, SPG5,
UGA1, URM1, VAC8, WHI2 and YNR029C) are also in
this group. These findings indicate that nutrient sensing
and stress signaling pathways are required for the growth
of the glc7-E101Q mutant. This group of interactions can
be related to a previous observation that mutation of
RHR2, encoding the DL-glycerol-3-phosphatase, is lethal
when introduced in a glc7-Y170 background [54]. In addi-
tion, epistasis and transcriptional analyses have shown a
role for Bud14-Glc7 in the regulation of Msn2, a transcrip-
Biological processes overrepresented in glc7-E101Q SSL genes Figure 4
Biological processes overrepresented in glc7-E101Q SSL genes. Indicated are the frequencies of high-level GO terms 
represented in the set of SSL genes (closed bars) that were significantly enriched (p < 0.01, **; p < 0.05, *) when compared to 
those represented in the set of array genes (open bars). The number of genes identified in each GO process is shown in paren-
theses.
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tion factor controlling the expression of stress-response
element (STRE)-genes [55].
Genes with a role in mitochondrial activity and inherit-
ance included subunits of the ATP synthase (ATP4 and
ATP12), genes required for cytochrome-c oxidase function
(COX19, CYC7 and SCO1), genes involved in mitochon-
drial replication (RIM1)-transcription (HAP2, MTF1 and
PET122) and -translation (MSK1,  RML2  and  RSM18),
genes required for mitochondrial homeostasis/metabo-
lism (CBR1, MIR1, MRS4 and PDX1) and genes with a
role in mitochondrial morphology and distribution
(IMP1,  MDM34  and  YPT11). This group also contains
genes that localize to the mitochondria (FMP42, PUT2,
VPS73,  YBL095W,  YGL059W,  YGR021W,  YGR287C,
YHR161W,  YJR039W  and  YNL320W) and may be
required for optimal mitochondrial function. Thus, mito-
chondrial function is essential when PP1 function is com-
promised.
Transcription, protein synthesis and protein regulation genes
Genes involved in transcription included transcription
factors (CAF120, DAT1,DST1, HMS2, and SUM1), elonga-
tor complex components (ELP2  and  KTI12), mediator
complex components (NUT1, SSN2 and SSN8), a tran-
scription termination factor (RTT103) and RNA process-
ing factors (CDC40 and LSM6). Protein synthesis genes
included components of the large ribosomal subunit
(RPL6B, RPL12A, RPL19A, RPL24A and RPL37), compo-
nents of the small ribosomal subunit (RPS1A, RPS16A,
RPS19A and RPS25A) and YBL054W, which is putatively
involved in rRNA synthesis. Other genes were identified
with various roles in protein modification such as protein
glycosylation (KTR1, KTR3, KTR4 and PMT5), ubiquitin-
regulated protein degradation (NPL4, OTU1, SLX8, UMP1
and USA1) and protein phosphorylation (PPZ1, PPM1
and RTS3). All these genes likely play a role in the expres-
sion of and/or the modification/turnover gene products
essential for processes buffered by Glc7.
The synthetic lethal interaction of glc7-E101Q with the
PPZ1 phosphatase and two PP2A subunits (PPM1 and
RTS3) suggests an interplay between these phosphatases.
Few synthetic lethal interactions are currently available for
PPZ1, PPM1 and RTS3. However, it was interesting to note
that glc7-E101Q and PPZ1 share synthetic lethal interac-
tions with both BIM1 and BUB3. In addition, it has been
previously suggested that an exchange of regulatory subu-
nits between Glc7 and PPZ phosphatase may be the basis
for the observed synthetic lethal interaction of glc8 with
glc7 mutants and ppz1 ppz2 [56]. These observations sup-
port that signaling cross-talk occurs between these phos-
phatases.
Vesicle transport, lipid metabolism and S-adenosylmethionine 
synthesis genes
Genes with a role in vesicle transport included ARF1 (coat
formation small GTPase), BTS1 (geranygeranyl diphos-
phate synthase required for the interaction of small
GTPases with vesicle/organelle membranes), regulators of
Golgi vesicle targeting and fusion (COG complex subunit
COG5, the TRAPP subunit GSG1, and the Ypt1 GTPase
Activating Protein, GYP8) and regulatory proteins
involved in endocytosis (actin cytoskeleton regulator,
END3, phosphoinositide-binding protein, ENT5, and the
coat regulators, MST27  and  UBP3). These interactions
may indicate a requirement for the transport of specific
cargo(s) in the glc7-E101Q mutant that are required for
viability. Alternatively, they may reflect a more direct role
for Glc7 in the regulation of vesicle transport. This is sup-
ported by previous studies that indicate a regulatory func-
tion for Glc7 on components of vesicle trafficking. For
example, Glc7 and its targeting subunit, Scd5, were shown
to regulate Pan1, an actin regulatory protein involved in
endocytosis. Interestingly, both Pan1 and End3 (identi-
fied in our SGA analysis) exhibited physical interactions
with Scd5, implicating them in Glc7 recruitment to sites
of endocytosis [57]. In addition, a separate study demon-
strated a role for Glc7 in the regulation of SNARE protein
complexes that are required for vesicle-membrane fusion
[58].
Lipid metabolism genes identified included those func-
tioning in ergosterol metabolism (ERG5 and OSH3), fatty
acid metabolism (ANT1  and  PCS60), phospholipid
metabolism (OPI3, PLB1, PSD1 and SCS3) and a set of
genes for peroxisomal proteins (PEX6, PEX29 and PEX31).
The intimate synthetic lethal relationships between lipid
metabolism, mitochondrial function and vesicle transport
genes is probably the basis for this set of SSL interactions.
Genes involved in S-adenosylmethionine (SAM) -depend-
ent processes included methyltransferases (BUD23,
NCL1,  RMT2  and  TRM1) and the SAM decarboxylase
SPE2. The deletion of these genes likely impacts on SAM
pool and this, in turn, affects Glc7-dependent processes
that utilize this co-factor such as histone methylation,
ergosterol synthesis and phospholipid synthesis.
Network analysis of the Glc7 interacting genes
We performed a network analysis of the glc7-E101Q SSL
genes by examining protein-protein and genetic interac-
tions available from the BioGRID database (version
2.0.41, released on June 1, 2008 [26]). This analysis
revealed 95 genes that are interconnected through 99 and
212 protein-protein and genetic interactions, respectively.
Based on protein-protein interactions, we identified 23
distinct molecular modules involving 72 GLC7  genetic
interactors (Figure 5). These modules are components ofBMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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molecular machines involved in microtubule-based
polarity, the spindle checkpoint, chromatin remodeling
and transcription, translation, regulation of casein kinase
2, regulation of the V-ATPase, nuclear pore complex and
nucleo-vacuolar transport. Some modules are intercon-
nected by genetic interactions among their components
(Figure 5, red edges). For example, components of the
"microtubule-based polarity", the "spindle checkpoint"
and the "nuclear pore complex" modules show genetic
interactions. This reflects how these modules cooperate
during mitosis. In some cases, two modules are connected
by genetic interaction with a gene that is not part of any
module. For example, CTF8 and SLX8, both playing a role
in the control of DNA replication, connect via genetic
A network of protein-protein and genetic interactions among glc7-E101Q SSL genes Figure 5
A network of protein-protein and genetic interactions among glc7-E101Q SSL genes. Genes showing SSL interac-
tion with glc7-E101Q (nodes) were grouped in modules based on their physical interaction profiles (blue edges). The genetic 
interactions interconnecting modules or connecting modules and single nodes are depicted as red edges.BMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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interactions to the "microtubule-base polarity", "nuclear
pore complex" and "remodeling/transcription" modules.
Finally, some modules, such as "NPL4-OTU1" (whose
products are involved in polyubquitin-mediated protein
degradation) and "AXL2-BUD4", are not connected to any
other module. This probably reflects that the map for
genetic interactions is still incomplete and that some
genes showing SSL interaction with glc7-E101Q have not
yet been screened by the SGA. Additional SGA screens will
be required to obtain a comprehensive interaction profile
for these genes.
Discussion
A number of studies support that Glc7 plays a critical role
in the regulation of several cellular processes such as cell
polarity, chromosome segregation, cytokinesis, and cell
cycle control [1-4]. However, the precise role of Glc7 in
the majority of these processes and the identity of Glc7
substrates involved in the regulation of these events
remains poorly understood. The lack of information
regarding Glc7's signaling network is due, in part, to a
large disconnect between genetic and proteomic data
available. Currently, the number of protein-protein inter-
actions reported greatly exceeds genetic interactions
[26,59,60]. The genetic interaction space, however, is
much more dense than the physical interaction network,
and the number of SSL combinations for a given gene is
estimated to be 4-times that of protein-protein interac-
tions [13]. The high number of physical interactions and
diverse phenotypes of conditional glc7 mutants suggest
Glc7 has a large and complex SSL interaction network.
In order to expand the genetic interaction data set for
Glc7, we examined a novel catalytic mutant, glc7-E101Q,
for synthetic lethal interactions using SGA. Existing condi-
tional glc7 alleles contain mutations outside of the Glc7
catalytic domain that can alter the binding of regulatory
subunits [1,18,19,22,25], potentially resulting in allele-
specific genetic interaction patterns. To achieve our goal
to globally map the GLC7 genetic interactions, a hypo-
morphic glc7 allele was constructed. Based on 3-dimen-
sional modeling and previous structure-function studies,
the SGA query mutant glc7-E101Q  was predicted to
exhibit reduced catalytic efficiency while maintaining
structural similarity to wild type GLC7. That two iron
transporter genes (FET3 and MRS4), were found in our
SGA analysis suggested that a normal iron supply is
important for the normal growth of the glc7-E101Q
mutant, and is consistent with the idea that this allele is
catalytically compromised due to altered metal cofactor
binding. Furthermore, phenotypic analyses indicated glc7-
E101Q is a stable recessive hypomorphic allele. Similar to
some conditional glc7 mutants, glc7-E101Q cells exhib-
ited impaired growth in glucose-limited medium and
defects in glycogen accumulation [16,22,36]. However, in
contrast to other glc7 mutants that have been shown to
have chromosome mis-segregation and cell cycle progres-
sion defects (e.g.: glc7-10 [1,32], glc7-129 [29] and glc7-
Y170 [31]), glc7-E101Q cells had no appreciable cell cycle
delay or chromosome loss. These observations suggest a
threshold effect may occur in glc7-E101Q cells, such that
weakened catalytic efficiency of Glc7 is tolerated and/or
compensated at differing levels depending on the cellular
process and the demand for Glc7 activity.
SGA analysis of glc7-E101Q resulted in a large number
(786) of SSL hits in two separate screens. We expect that
the large number of genes identified be due, at least in
part, to the haploinsufficiency observed for glc7-E101Q
mutants, which resulted in reduced spore viability and
placed constraints on colony scoring. To solve this prob-
lem and generate a high confidence dataset, we modified
the confirmation procedure by creating a second query
strain that expressed a selectable copy of wild type GLC7
(GLC7-res). Sporulation, meiosis and growth of haploid
progeny were performed in glc7-E101Q cells expressing
wild type GLC7 inserted at the URA3 locus. Pinning on
counter-selective medium then eliminated haploid cells
expressing the wild type GLC7 allele. Using this strategy,
false positive hits were rejected and 245 hits were con-
firmed as true SSL interactions. We anticipate this strategy
may be applicable to confirm SGA screens of other query
genes that interfere with sporulation or spore germina-
tion.
Genes showing synthetic sick/lethal interactions with
glc7-E101Q  were grouped in 12 functional classes.
Although only one (BUD14) of 7 previously reported SSL
interactions (BUD14, DAM1, DOC1, GLC8, RHR2, SET1
and  SLT2) for GLC7  was identified in our analysis, a
number of established Glc7-mediated processes were cap-
tured in our screen. In particular, sets of genes fall into
functional classes encompassing the 7 previously reported
GLC7 SSL interactions, which are chromatin remodeling,
chromosome segregation/cytokinesis, and nutrient sens-
ing/metabolism. In addition, certain SSL genes identified
highlight events that appear to be directly regulated by
Glc7. These include genes involved in glucose repression
(SIP5) [39], chromosome segregation (BUD14) [18] and
endocytosis (END3) [57]. Lastly, our SGA analysis of glc7-
E101Q provides a rich data set of genetic interactions that
expands on previously known Glc7-regulated processes,
and the glc7-E101Q synthetic interaction pattern reveals
new facets of Glc7 function. For example, the requirement
for mitochondrial and phospholipid metabolism genes
when Glc7 function is compromised suggests a role for
Glc7 in these processes.BMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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Conclusion
To uncover the genetic interaction network of the essential
PP1 gene GLC7, a novel catalytic mutant allele, glc7-
E101Q, was used in an unbiased genome-wide screen for
SSL interactions. We found 245 genes whose deletion was
detrimental for the growth of glc7-E101Q. Functional
grouping of these genes and analysis of their physical and
genetic interaction expand the genetic network of estab-
lished Glc7-regulated processes and suggest novel regula-
tory roles for Glc7.
Methods
Media, growth conditions and strain manipulations
Yeast strains (Table 1) were created through PCR-based
transformation [61,62]. Media (rich media: YPAD and
YPD (2% glucose), YPAG (3% glycerol with 0.08% glu-
cose); synthetic media: SC and SD) were prepared as pre-
viously described [63]. Standard methods for culture of
yeast strains and integrative transformation, mating,
sporulation and tetrad analysis was performed as previ-
ously described [63]. SGA analysis was performed in
strains derived from the S288C diploid BY4743 [64]. All
other analyses were performed in strains derived from the
S288C diploid Y270 [65].
Mutagenesis of Glc7 and strain construction
A 1.2 kb PCR product containing 3' sequence of the GLC7
ORF was cloned into pBSK using KpnI and NotI to create
pGLC7-1. The KANMX4 selection cassette was amplified
by PCR from pFA6A-KANMX4, digested with NotI and
SacI and cloned into pGLC7-1, creating pGLC7-KANMX4.
This construct was used as a template for PCR-based
mutagenesis of the catalytic domain at codon 273 (D91N:
GAT to AAT) and codon 303 (E101Q: GAG to CAG). A
silent restriction site (AvrII  in D91N and HindIII  in
E101Q) was introduced into the mutagenic 5' primer to
mark the mutation. Mutagenic PCR products were trans-
formed into Y270 as previously described [65], and G418-
resistant transformants selected for on YPAD containing
200  μg/ml G418 (GIBCO). Integration into the GLC7
locus was confirmed by amplification of a PCR product
that spanned the ORF and the KANMX4 cassette and by
restriction digest with AvrII or HindIII. Finally, the pres-
ence of a single point mutation (D91N or E101Q) in the
ORF and no others was confirmed by sequencing. Diploid
strains heterozygous for D91N (YNS19) and E101Q
(YNS53) mutations were sporulated, and haploid glc7-
E101Q:KANMX4  MATa and MATa segregants (YNS91,
YNS90) isolated for phenotypic analyses. A similar clon-
ing strategy was used to create ProA fusions of both wild
type GLC7 and glc7-E101Q. A Glc7 PCR product lacking
the endogenous stop codon was cloned into pBSK
(pGLC7-2) and the ProA and KANMX4 selectable markers
from pFA6A-ProA-KANMX4 [66] integrated using NotI
and SacI, creating pGLC7-ProA. This construct was used
for PCR directed mutagenesis and transformation into
Y270 as described above, sporulated and haploid segre-
gants (YNS26, YNS27) isolated for the analysis of protein
stability. Wild type GLC7-proA strains were derived in a
similar manner (YNS23, YNS44).
For glc7-E101Q rescue experiments, a GLC7 was cloned
into the integrative plasmid pRS306 by first amplifying a
PCR product from genomic DNA that contained the entire
GLC7 ORF and 0.5 kb 5' promoter sequence and 0.3 kb 3'
UTR, digested with KpnI and SacI and ligated into pRS306
[67], resulting in pGLC7-3. pGLC7-3 was linearized with
StuI, and transformed into the ura3 locus of the hetero-
zygous diploid strain YNS53. Integration at the ura3 locus
resulted in wild type copy of GLC7 marked with URA3
(GLC7-res; strains YNS138, YNS141) on the opposite arm
(116167–116970) of chromosome V relative to the GLC7
locus (432491–433954). In ~40 meiotic events GLC7-res
segregated as an un-linked gene (28TT : 3NPD : 9PD)
independently of GLC7 and glc7-E101Q.
To create the SGA query strain, YNS98, a NATMX4 PCR
product with homology to the GLC7 3' UTR sequences
was amplified by PCR from p4339 [12], and used to
replace the KANMX4 cassette in YNS90. Genomic DNA of
the resulting strain was then used to amplify a PCR prod-
uct containing the E101Q mutation and the NATMX4 cas-
sette. This PCR product was transformed into Y5563
according to previously described methods [13]. To create
the query strain for random spore analysis (YNS100), a
MATa glc7-E101Q:NATMX4/GLC7-res strain was first iso-
lated by tetrad dissection from a heterozygous diploid
(YNS99 × YNS98) and then backcrossed to Y5663.
Growth assays, FACS and glycogen staining
To assess cell growth, wild type (YNS3) and glc7-E101Q
(YNS91) and GLC7-res (YNS138) strains were grown to
mid-log phase in YPAD, diluted to 5.5 × 105 cells/ml
(~0.05 OD units) and incubated at 30°C for a total of 7
hours. Cells were collected at 1-hour intervals, and cell
density determined using a hemocytometer. For spotting
assays, log phase cells grown in liquid YPAD were diluted
to 1.0 × 106 cells/ml (~0.1 OD units) and 5-fold serial
dilutions spotted (5 μl/spot) to YPAD or YPAG plates and
incubated for 2–3 days at 18°C, 25°C, 30°C and 37°C.
To determine benomyl-sensitivity, cells were examined in
parallel with benomyl-sensitive (tub1-1) and resistant
(tub2-104) strains [68,69] on 10 μg/ml benomyl or
DMSO plates incubated for 2–3 days at 30°C. Cell cycle
progression of wild type and glc7-E101Q strains was deter-
mined by FACS analysis as previously described [70].
Fixed cells from the FACS analysis were also used for bud
index scoring, and the proportion of un-budded, small-
budded (bud <50% mother cell) and large-budded cells
determined. Cells were pre-treated with Zymolase (20 μg/BMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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Table 1: Yeast strains used in this study
Strain Genotype Source
BY4743 MATa/α ura3Δ0/ura3Δ0 leu2Δ0/leu2Δ0 his3Δ1/his3Δ1 
LYS2/lys2Δ0 met15Δ0/MET15
[64]
Y270 MATa/MATα ura3-52/ura3-52 lys2-801/lys2-801 ade2-101/
ade2-101 trp1Δ1/trp1Δ his3Δ200/his3Δ200
[65]
Y5563 MATa can1Δ::MFA1pr-HIS3 lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 C Boone
ΔArrayORF MATa orfΔ::KanMX4 LYS2 his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 [71]
YNS2 MATα ura3-52 lys2-801 ade2-101 trp1Δ1 his3Δ200 This study
YNS3 MATa ura3-52 lys2-801 ade2-101 trp1Δ1 his3Δ200 This study
YNS19 MATa/MATα glc7-D91N:KanMX4/GLC7 ura3-52/ura3-52 
lys2-801/lys2-801 ade2-101/ade2-101 trp1Δ1/ trp1Δ1 
his3Δ200/his3Δ200
This study
YNS23 MATa GLC7:ProA:KanMX4 ura3-52 lys2-801 ade2-101 
trp1Δ1 his3Δ200
This study
YNS26 MATα glc7-E101Q:ProA:KanMX4 ura3-52 lys2-801 ade2-101 
trp1Δ1 his3Δ200
This study
YNS27 MATa glc7-E101Q:ProA:KanMX4 ura3-52 lys2-801 ade2-101 
trp1Δ1 his3Δ200
This study
YNS44 MATα GLC7:ProA:KanMX4 ura3-52  
lys2-801 ade2-101
This study
YNS53 MATa/MATα glc7-E101Q:KanMX4/GLC7 ura3-52/ura3-52 
lys2-801/lys2-801 ade2-101/ade2-101 trp1Δ1//trp1Δ1 
his3Δ200/his3Δ200
This study
YNS90 MATα glc7-E101Q:kanMX4 ura3-52 lys2-801 ade2-101 trp1Δ1 
his3Δ200
This study
YNS91 MATa glc7-E101Q:KanMX4 ura3-52 lys2-801 ade2-101 
trp1Δ1 his3Δ200
This study
YNS98 MATα glc7-E101Q:NatMX4 can1Δ::MFA1pr-HIS3 lyp1Δ 
his3Δ1 leu2Δ0 ura3Δ0 met15Δ0
This study
YNS99 MATa ura3-52::GLC7:URA3 lys2-801 ade2-101 trp1Δ1 his3Δ200 This study
YNS100 MATα glc7-E101Q:NatMX4 ura3-52::GLC7:URA3 
can1Δ::MFA1pr-HIS3 lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0
This study
YNS101 MATa his3-11,15::GFP:LacI:HIS3 lacO:URA3, 
SPC29:CFP:kanMX4 lys2-801 ade2-101 trp1Δ1
This study
YNS102 MATa glc7-E101Q:kanMX4 his3-11,15::GFP:LacI:HIS3 
lacO:URA SPC29:CFP:kanMX4 lys2-801 ade2-101 trp1Δ1
This study
YNS128 MATa/MATα glc7-E101Q:KanMX4/GLC7 ura3-52/ ura3-52:
:GLC7:URA3 lys2-801/lys2-801 ade-101/ade2-101 trp1Δ1/trp1Δ1 
his3Δ200/his3Δ200
This study
YNS138 MATa glc7-E101Q:KanMX4 ura3-52::GLC7::URA3 lys2-801 ade2-101 
trp1Δ1 his3Δ200
This study
YNS141 MATα glc7-E101Q:KanMX4 ura3-52::GLC7::URA3 lys2-801 ade2-101 
trp1Δ1 his3Δ200
This studyBMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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ml) to complete cell separation. Glycogen staining was
performed as previously described [40]. Briefly, after 2-
day incubation at 30°C, plates were exposed to iodine
crystals (Sigma) for 1 minute, removed for 15 sec and
exposed again for 2 min. Digital images were captured
immediately after exposure to iodine.
Analysis of chromosome segregation
Microscopy
MATa wild type (YNS101) and glc7-E101Q  mutant
(YNS102) strains that expressed Spc29-CFP (SPB marker),
GFP-LacI and centromeric (CEN15) lacO repeats [34]
were isolated from heterozygous diploids. Cells were
incubated in 5 μg/ml a-factor for 3 hrs at 30°C, washed
and released in YPAD and collected every 10 min (80 min
total). Samples were fixed for 5 min in 4% formaldehyde,
washed three times in PBS and imaged using a Nikon
TE200 inverted microscope equipped with a 100 × 1.4 NA
objective mounted on PE piezo z-drive/Improvision Orbit
controller and Hammamatsu ORCA-ERG camera. Image
stacks (0.5 μm sections, 10–12/image) were acquired
using Volocity 4.0 and image deconvolution with Volocity
4.0 Restoration.
Sectoring assay
MATa wild type (YNS3), glc7-E101Q (YNS91) and ame1-6
(positive control for chromosome loss; Vogel unpub-
lished data) strains lacking a functional ADE2  gene
(ade2Δ-101) were transformed with a circular fragment of
chromosome III encoding SUP11 (Circle III/SUP11) [35]
and incubated for 4 days on YPD at 30°C. SUP11 sup-
presses the ade2Δ-101 mutation resulting in the formation
of white colonies. Loss of the CircleIII/SUP11 (an indica-
tor of chromsome mis-segregation) was identified by the
restoration of the ade2Δ-101 mutant phenotype causing
the accumulation of P-ribosylaminoimidazole, a red
colored pigment [41].
Synthetic genetic array (SGA) analysis of glc7-E101Q
Two-independent SGA screens were performed in tripli-
cate using the ordered deletion array and Virtek pinning
robot system as previously described [12,13,71]. The sizes
Table 2: Functional processes of 163 genes showing SSL interactions with glc7-E101Q
Functional category Genes
Cell polarity AXL2, BUD4
Chromosome segregation BAG7, BIM1, BNR1, BOI2, BUB1, BUB3, BUD14, CIK1, CTF8, KAP120, KAR3, MAD1, MAD2, MCM22, NUP53, 
NUP84, NUP133, REC8, ROM2, SXM1, TUB3
DNA damage EXO1, IES2, LIF1, LSM12, MRC1, PMS1, RAD4, RAD14, RFX1, RSC2, TDP1, UNG1, YFR017C, YPR147C
Histone modification ASF1, CHD1, DOT1, FPR4, PHO23, RTT109, UAF30
Lipid metabolism ANT1, BUD25, ERG5, OPI3, OSH3, PCS60, PEX6, PEX29, PEX31, PLB1, PSD1, SCS3
Mitochondrial function ATP4, ATP12, CBR1, COX19, CYC7, FMP42, HAP2, IMP1, MDM34, MIR1, MRS4, MSK1, MTF1, PDX1, PET122, 
PUT2, RIM1, RML2, RSM18, SCO1, VPS73, YPT11, YBL095W, YGL059W, YGR021W, YGR287C, YHR162W, 
YJR039W, YNL320W
Nutrient sensing and stress signaling ATG5, ATG15, BAP2, CKB1, CKB2, GPA2, GPH1, HIT1, HXT17, MCA1, MCH4, NST1, NVJ1, ORM2, SAK1, SFL1, 
SIP5, SPG5, SSK1, TDH3, TPK1, UGA1, URM1, VAC8, WHI2, YBR235W, YJL193W, YNR029C
Phosphatase genes PPM1, PPZ1, RTS3
Protein modification and degradation KTR1, KTR3, KTR4, NAT3, NPL4, OTU1, PMT5, SLX8, UMP1, USA1
Protein synthesis RPL6B, RPL12A, RPL19A, RPL24A, RPL37A, RPS1A, RPS16A, RPS19A, RPS25A, YBL054W
SAM(1) synthesis BUD23, NCL1, RMT2, SPE2, TRM1
Transcription CAF120, CDC40, DAT1, DST1, ELP2, HMS2, KTI12, LSM6, NUT1, RTT103, SSN2, SSN8, SUM1
Vesicular transport ARF1, BTS1, COG5, END3, ENT5, GSG1, GYP8, MST27, UBP3
(1): S-adenosylmethionineBMC Genomics 2008, 9:336 http://www.biomedcentral.com/1471-2164/9/336
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of the resulting colonies were measured from digital
images of the plates. A comparative set of mutant meas-
urements relative to wild type control measurements ena-
bled t-statistics and p-values to be calculated [13]. Double
mutants that showed significantly reduced colony sizes (p
< 0.05) were scored as hits. Hits identified in the SGA
screens were evaluated by a modified spot assay version of
random spore analysis [13] using a glc7-E101Q strain that
co-expressed GLC7-res (YNS100) (Additional File 3) and
finally scored as synthetic sick/lethal (SSL) or rejected as
false positive. Spores were initially grown for 2 days at
30°C on solid haploid selection medium [synthetic dex-
trose (SD) medium lacking histidine and arginine but
containing canavanine: SD - His/Arg + canavanine]. MATa
spore progeny were transferred to solid 5-fluoro-orotic
acid (5-FOA) medium [45] and incubated at 30°C for 2
days to eliminate cells expressing GLC7-res. Cells were
inoculated to microtiter plates in 250 μl of liquid SD -
His/Arg + canavanine for 2 days at 30°C. A Biomek FX
robot (Beckman Coulter, Inc; CIAN robotics facility,
McGill University) was used to perform serial dilutions
and spotting to four different solid medium plates: SD/
MSG (monosodium glutamic acid) - His/Arg + cana-
vanine/nourseothricin, SD/MSG - His/Arg + canavanine/
G418, SD/MSG - His/Arg +canavanine/nourseothricin/
G418, and SD/MSG - His/Arg/Ura + canavanine. Colony
growth was scored following incubation for 2 days at
30°C.
Protein extraction, 1D and 2D-SDS-PAGE
All steps were performed at 4°C unless otherwise indi-
cated. Log phase yeast cultures were harvested and washed
in PGSK+ buffer (PGSK+: 50 mM NaPO4, 50 mM NaCl, 5
mM KCl, 60 mM glucose, 4% CHAPS, 50 mM DTT, 5 μM
yeast protease inhibitors [Sigma P8215], 5 μM PMSF, 5
μM ortho-vanadate, 5 μM NaF, and 5 mM β-glycerol
phosphate) and pelleted by centrifugation. Cell pellets
were suspended in 2 volumes of PGSK+, and an equal vol-
ume of zirconium beads (Biospec Products) added, and
cells lysed by vortexing for 12–15 min. Extracts were
cleared by centrifugation for 10 min at 13,000 × g. For 1D
SDS-PAGE, extracts were re-suspended in an equal vol-
ume of 2× SDS sample buffer [72] and denatured at 95°C
for 5 min. For 2D-SDS-PAGE and 2D-DiGE, extracts were
treated with 50 μg/ml DNAse and RNAse (Worthington)
for 15 minutes, precipitated with methanol/chloroform
and re-suspended in labeling buffer (2 M thiourea, 7 M
urea, 30 mM Tris, 4% CHAPS) at 25°C and the protein
concentration determined (Biorad Protein Assay). For 2D-
SDS-PAGE analysis of GLC7-ProA  (YNS23) and glc7-
E101Q-ProA (YNS27), 30 μg was loaded to 7 cm pH 4–7
Readystrip IPG strips (Biorad) and rehydration and focus-
ing carried out according to the manufacturer's instruc-
tions.
Immunoblotting
Immunoblotting was performed as previously described
[65]. Briefly, proteins extracts prepared from GLC7-ProA
(YNS23, YNS44) and glc7-E101Q-ProA (YNS26, YNS27)
strains were separated on 1D or 2D-SDS-PAGE gels, trans-
ferred to PVDF membranes (Millipore) and probed with
anti-ProA monoclonal antibodies (1:5000; clone SPA-27,
Sigma). Actin was detected using the monoclonal anti-
bodies (1:5000; clone C4, MP Biomedical). Protein/anti-
body complexes were detected using anti-mouse HRP-
conjugated secondary antibodies (1:10,000; GE Health-
Care) and ECL chemiluminescence (Pierce).
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